A

AdoRx

10 employees

AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2017

Funding rounds raised

Total raised

$10M

from 2 investors over 2 rounds

A

AdoRx raised $10M on June 21, 2018

Investors: SIXTH ELEMENT CAPITAL LLP and Epidarex Capital

FAQ